Raj Kalkeri

941 total citations
34 papers, 472 citations indexed

About

Raj Kalkeri is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Raj Kalkeri has authored 34 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 13 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Raj Kalkeri's work include SARS-CoV-2 and COVID-19 Research (19 papers), COVID-19 Clinical Research Studies (7 papers) and Mosquito-borne diseases and control (6 papers). Raj Kalkeri is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (19 papers), COVID-19 Clinical Research Studies (7 papers) and Mosquito-borne diseases and control (6 papers). Raj Kalkeri collaborates with scholars based in United States, Belgium and Australia. Raj Kalkeri's co-authors include Scott J. Goebel, Fusataka Koide, Beth A. Snyder, Kevin Walters, Jonathan O. Rayner, Roger G. Ptak, Zhaohui Cai, John T. Manning, Mingzhu Zhu and Jeanon N. Smith and has published in prestigious journals such as Scientific Reports, Journal of Allergy and Clinical Immunology and Journal of Medicinal Chemistry.

In The Last Decade

Raj Kalkeri

28 papers receiving 450 citations

Peers

Raj Kalkeri
Su Hui Catherine Teo Singapore
Ruoke Wang China
Qingrui Huang China
Giulia Torriani Switzerland
Panke Qu United States
Melanie H. Dietrich Australia
Mallorie E. Fouch United States
Aurelio Bonavia United States
Meagan Bolles United States
Gabriele Anichini Italy
Su Hui Catherine Teo Singapore
Raj Kalkeri
Citations per year, relative to Raj Kalkeri Raj Kalkeri (= 1×) peers Su Hui Catherine Teo

Countries citing papers authored by Raj Kalkeri

Since Specialization
Citations

This map shows the geographic impact of Raj Kalkeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raj Kalkeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raj Kalkeri more than expected).

Fields of papers citing papers by Raj Kalkeri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raj Kalkeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raj Kalkeri. The network helps show where Raj Kalkeri may publish in the future.

Co-authorship network of co-authors of Raj Kalkeri

This figure shows the co-authorship network connecting the top 25 collaborators of Raj Kalkeri. A scholar is included among the top collaborators of Raj Kalkeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raj Kalkeri. Raj Kalkeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalkeri, Raj, Mingzhu Zhu, Anand Parekh, et al.. (2025). Anti-spike IgG4 and Fc effector responses: The impact of SARS-CoV-2 vaccine platform–specific priming and immune imprinting. Journal of Infection. 91(2). 106543–106543. 1 indexed citations
2.
3.
Kotloff, Karen L., R. Scott McClelland, Joyce S. Plested, et al.. (2025). Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2/3 study. The Lancet Infectious Diseases. 25(5). 585–594. 5 indexed citations
4.
5.
Bennett, Chijioke, Gordon Chau, Elizabeth Clayton, et al.. (2025). Safety and immunogenicity of Omicron protein vaccines in mRNA-vaccinated adolescents: A phase 3, randomised trial. Journal of Infection. 90(2). 106428–106428.
6.
7.
Zhu, Mingzhu, et al.. (2024). Validation of a severe acute respiratory syndrome coronavirus 2 microneutralization assay for evaluation of vaccine immunogenicity. Journal of Virological Methods. 327. 114945–114945. 3 indexed citations
8.
Fries, Louis, Hadi Beyhaghi, Mingzhu Zhu, et al.. (2024). Mechanisms and implications of IgG4 responses to SARS-CoV-2 and other repeatedly administered vaccines. Journal of Infection. 89(6). 106317–106317. 6 indexed citations
9.
10.
Davis, Matthew, Jeffrey Adelglass, Gordon Chau, et al.. (2023). Immunogenicity and safety of NVX-CoV2373 as a booster: A phase 3 randomized clinical trial in adults. Vaccine. 41(41). 5965–5973. 5 indexed citations
11.
Plested, Joyce S., Gordon Chau, Shane Cloney-Clark, et al.. (2023). Immunogenicity and safety of a fourth homologous dose of NVX-CoV2373. Vaccine. 41(29). 4280–4286. 12 indexed citations
12.
Patel, Nita, Jessica F. Trost, Mimi Guebre‐Xabier, et al.. (2023). XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants. Scientific Reports. 13(1). 19176–19176. 36 indexed citations
13.
Kalkeri, Raj, et al.. (2021). SARS-CoV-2 Spike Pseudoviruses: A Useful Tool to Study Virus Entry and Address Emerging Neutralization Escape Phenotypes. Microorganisms. 9(8). 1744–1744. 19 indexed citations
14.
Kalkeri, Raj, Kevin Walters, William Van Der Pol, et al.. (2021). Changes in the gut microbiome community of nonhuman primates following radiation injury. BMC Microbiology. 21(1). 93–93. 21 indexed citations
15.
Kalkeri, Raj, et al.. (2020). HBV Core Promoter Inhibition by Tubulin Polymerization Inhibitor (SRI-32007). Advances in Virology. 2020. 1–8. 4 indexed citations
16.
Prow, Natalie A., Liang Liu, Mary K. McCarthy, et al.. (2020). The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates. npj Vaccines. 5(1). 44–44. 17 indexed citations
17.
Mueller, Steffen, Charles B. Stauft, Raj Kalkeri, et al.. (2020). A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates. Vaccine. 38(14). 2943–2948. 40 indexed citations
18.
Snyder, Beth A., Scott J. Goebel, Fusataka Koide, Roger G. Ptak, & Raj Kalkeri. (2017). Synergistic antiviral activity of Sofosbuvir and type‐I interferons (α and β) against Zika virus. Journal of Medical Virology. 90(1). 8–12. 24 indexed citations
19.
Koide, Fusataka, Scott J. Goebel, Beth A. Snyder, et al.. (2016). Development of a Zika Virus Infection Model in Cynomolgus Macaques. Frontiers in Microbiology. 7. 2028–2028. 76 indexed citations
20.
Goebel, Scott J., Beth A. Snyder, Timothy J. Sellati, et al.. (2016). A sensitive virus yield assay for evaluation of Antivirals against Zika Virus. Journal of Virological Methods. 238. 13–20. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Su Hui Catherine Teo Breakdown of academic impact, for papers by Ruoke Wang Breakdown of academic impact, for papers by Qingrui Huang Breakdown of academic impact, for papers by Giulia Torriani Breakdown of academic impact, for papers by Panke Qu Breakdown of academic impact, for papers by Melanie H. Dietrich Breakdown of academic impact, for papers by Mallorie E. Fouch Breakdown of academic impact, for papers by Aurelio Bonavia Breakdown of academic impact, for papers by Meagan Bolles Breakdown of academic impact, for papers by Gabriele Anichini
Rankless by CCL
2026